Department of Neurology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, No 1, Shuaifuyuan, Dongcheng District, Beijing, 100730, China.
Neurol Sci. 2024 Dec;45(12):5639-5655. doi: 10.1007/s10072-024-07784-2. Epub 2024 Oct 2.
Idiopathic extracranial internal carotid artery vasospasm (IEICAV) is characterized by spontaneous, recurrent, and reversible vasoconstriction of the cervical internal carotid artery (ICA). The etiology remains elusive, and no effective treatment has been established. The present study presents a case of recurrent IEICAV with migraine-like symptoms and conduct a systematic review on IEICAV.
A retrospective analysis was conducted on a case involving medical history, radiological data, treatment, and outcomes. A systematic review of published IEICAV cases was conducted through database searching in PubMed, Embase, and Web of Science from inception until May 2024.
A 22-year-old female with recurrent headaches, blurred vision, and aphasia was diagnosed with bilateral IEICAV through angiography. Magnetic resonance imaging demonstrated a novel cerebral infarction during a prolonged episode. Treatment with topiramate successfully controlled recurrence in a 5-month follow-up. The systematic review included 36 IEICAV cases reported by literature. Bilateral involvement of extracranial ICAs was observed in 25 (69.4%) cases. Cerebral infarction was identified in 31 (88.9%) cases. Despite various treatment attempts including vasodilators, antiplatelet, anticoagulants, glucocorticoids, and other medical or surgical intervention, the recurrent rate increased in 5 (13.9%) cases, decreased in 10 (27.8%) cases, and remained unchanged in 4 (11.1%) cases.
The elusive mechanism of IEICAV brings great difficulty into managing recurrence. Preventing IEICAV-related infarction related to secondary factors like hypoperfusion may be crucial for maintaining life quality. Further research is essential for advancing treatment strategies and a case-by-case approach is needed in identifying and eliminating possible triggers for vasospastic episodes.
特发性颅外颈内动脉血管痉挛(IEICAV)的特征是颈内动脉(ICA)自发性、复发性和可逆性收缩。其病因仍不清楚,也没有确立有效的治疗方法。本研究报告了一例复发性 IEICAV 伴偏头痛样症状,并对 IEICAV 进行了系统回顾。
对一例涉及病史、影像学数据、治疗和结果的病例进行回顾性分析。通过在 PubMed、Embase 和 Web of Science 数据库中进行检索,对发表的 IEICAV 病例进行了系统回顾,检索时间从建库至 2024 年 5 月。
一名 22 岁女性,反复头痛、视力模糊和失语,经血管造影诊断为双侧 IEICAV。磁共振成像显示在一次长时间发作中出现新的脑梗死。在 5 个月的随访中,托吡酯治疗成功控制了复发。系统回顾包括文献报道的 36 例 IEICAV 病例。25 例(69.4%)病例存在颅外 ICA 双侧受累。31 例(88.9%)病例发现脑梗死。尽管尝试了各种治疗方法,包括血管扩张剂、抗血小板、抗凝剂、糖皮质激素和其他药物或手术干预,但 5 例(13.9%)病例的复发率增加,10 例(27.8%)病例的复发率降低,4 例(11.1%)病例的复发率保持不变。
IEICAV 的发病机制尚不清楚,给管理复发带来了很大的困难。预防与低灌注等继发性因素相关的 IEICAV 相关梗死可能对维持生活质量至关重要。需要进一步研究以推进治疗策略,并需要针对每个病例确定和消除可能引发血管痉挛发作的触发因素。